Biogen
BIIB
BIIB
1,025 hedge funds and large institutions have $53.8B invested in Biogen in 2016 Q4 according to their latest regulatory filings, with 137 funds opening new positions, 364 increasing their positions, 401 reducing their positions, and 107 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
9% less capital invested
Capital invested by funds: $59.3B → $53.8B (-$5.52B)
13% less call options, than puts
Call options by funds: $1.52B | Put options by funds: $1.74B
28% less funds holding in top 10
Funds holding in top 10: 57 → 41 (-16)
Holders
1,025
Holding in Top 10
41
Calls
$1.52B
Puts
$1.74B
Top Buyers
| 1 | +$371M | |
| 2 | +$314M | |
| 3 | +$152M | |
| 4 |
Renaissance Technologies
New York
|
+$133M |
| 5 |
Two Sigma Advisers
New York
|
+$126M |
Top Sellers
| 1 | -$701M | |
| 2 | -$430M | |
| 3 | -$142M | |
| 4 |
CCM
Causeway Capital Management
Los Angeles,
California
|
-$142M |
| 5 |
HM
HealthCor Management
New York
|
-$117M |